Seroatlas · Human Serome Atlas

GSTZ1

Maleylacetoacetate isomerase

Also known as: GSTZ1-1, MAAI, MAAI_HUMAN, MAI

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O43708
Gene
GSTZ1
Ensembl
ENSG00000100577
Chromosome
14
Canonical length
216 aa
Protein class
Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene is a member of the glutathione S-transferase (GSTs) super-family which encodes multifunctional enzymes important in the detoxification of electrophilic molecules, including carcinogens, mutagens, and several therapeutic drugs, by conjugation with glutathione. This enzyme catalyzes the conversion of maleylacetoacetate to fumarylacetoacatate, which is one of the steps in the phenylalanine/tyrosine degradation pathway. Deficiency of a similar gene in mouse causes oxidative stress. Several transcript variants of this gene encode multiple protein isoforms. [provided by RefSeq, Jul 2015]

Canonical amino-acid sequenceUniProt

216 residues, UniProt reviewed canonical sequence.

>O43708|GSTZ1
     1  MQAGKPILYS YFRSSCSWRV RIALALKGID YKTVPINLIK DRGQQFSKDF QALNPMKQVP
    61  TLKIDGITIH QSLAIIEYLE EMRPTPRLLP QDPKKRASVR MISDLIAGGI QPLQNLSVLK
   121  QVGEEMQLTW AQNAITCGFN ALEQILQSTA GIYCVGDEVT MADLCLVPQV ANAERFKVDL
   181  TPYPTISSIN KRLLVLEAFQ VSHPCRQPDT PTELRA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GSTZ1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
246 nTPM

Expression across tissuesHPA

Tissue

  • liver: 246 nTPM
  • testis: 56 nTPM
  • skeletal muscle: 44 nTPM
  • tongue: 35 nTPM
  • adrenal gland: 32 nTPM
  • choroid plexus: 26 nTPM

Single-cell type

  • late spermatids: 674 nCPM
  • hepatocytes: 483 nCPM
  • late primary spermatocytes: 149 nCPM
  • early spermatids: 119 nCPM
  • cytotrophoblasts: 112 nCPM
  • esophageal suprabasal cells: 90 nCPM

Immune cell

  • intermediate monocyte: 22 nTPM
  • myeloid DC: 21 nTPM
  • non-classical monocyte: 20 nTPM
  • classical monocyte: 16 nTPM
  • plasmacytoid DC: 15 nTPM
  • basophil: 13 nTPM

Brain region

  • white matter: 18 nTPM
  • cerebellum: 16 nTPM
  • medulla oblongata: 16 nTPM
  • pons: 15 nTPM
  • hypothalamus: 15 nTPM
  • spinal cord: 15 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GSTZ1.

Disease | AllUniProt

Conditions GSTZ1 is implicated in, by any mechanism.

Disease | GeneticClinVar

5 pathogenic / likely-pathogenic of 59 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.48
gnomAD pLI
0
gnomAD missense Z
-0.01
DepMap mean gene effect
0.02
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GSTZ1 as an antibody target. Whether an autoantibody or antibody against GSTZ1 could matter depends on whether native GSTZ1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GSTZ1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GSTZ1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GSTZ1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...